Hsbc Holdings PLC Emergent Bio Solutions Inc. Transaction History

Hsbc Holdings PLC

$159 Billion
Q1 2025

A detailed history of Hsbc Holdings PLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 18,137 shares of EBS stock, worth $117,709. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,137

Previous 18,727 3.15%

Holding current value

$117,709

Previous $179,000 50.84%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$4.66 - $11.66 $2,749 - $6,879	-590 Reduced 3.15%	18,137 $88,000
Q4 2024 Feb 14, 2025	SELL	$7.72 - $11.97 $130,807 - $202,819	-16,944 Reduced 47.5%	18,727 $179,000
Q3 2024 Nov 14, 2024	SELL	$5.72 - $14.77 $297,485 - $768,158	-52,008 Reduced 59.32%	35,671 $297,000
Q2 2024 Aug 12, 2024	BUY	$1.86 - $6.98 $43,245 - $162,285	23,250 Added 36.09%	87,679 $597,000
Q1 2024 May 15, 2024	SELL	$1.5 - $3.41 $108,342 - $246,297	-72,228 Reduced 52.85%	64,429 $163,000
Q4 2023 Feb 12, 2024	BUY	$1.82 - $3.16 $111,973 - $194,415	61,524 Added 81.89%	136,657 $327,000
Q3 2023 Nov 13, 2023	BUY	$3.17 - $7.91 $177,928 - $443,980	56,129 Added 295.35%	75,133 $255,000
Q2 2023 Aug 11, 2023	SELL	$7.35 - $13.21 $15,633 - $28,097	-2,127 Reduced 10.07%	19,004 $139,000
Q1 2023 May 15, 2023	SELL	$7.79 - $16.29 $52,309 - $109,387	-6,715 Reduced 24.11%	21,131 $218,000
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $306,306 - $597,296	27,846 New	27,846 $328,000
Q2 2022 Aug 11, 2022	SELL	$27.42 - $43.63 $112,860 - $179,581	-4,116 Reduced 20.41%	16,053 $508,000
Q1 2022 May 16, 2022	BUY	$36.48 - $52.22 $422,037 - $604,133	11,569 Added 134.52%	20,169 $841,000
Q4 2021 Feb 11, 2022	BUY	$33.11 - $55.01 $284,746 - $473,086	8,600 New	8,600 $373,000
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $3.73 Million - $5.42 Million	-43,277 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$79.17 - $111.47 $1.21 Million - $1.71 Million	-15,308 Reduced 26.13%	43,277 $3.88 Million
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $4.11 Million - $6.78 Million	50,210 Added 599.52%	58,585 $6.06 Million
Q2 2020 Aug 14, 2020	BUY	$54.33 - $89.52 $37,107 - $61,142	683 Added 8.88%	8,375 $662,000
Q1 2020 May 15, 2020	BUY	$49.34 - $68.76 $379,523 - $528,901	7,692 New	7,692 $445,000
Q2 2019 Aug 13, 2019	SELL	$39.92 - $53.86 $177,045 - $238,869	-4,435 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$48.23 - $66.16 $213,900 - $293,419	4,435 New	4,435 $223,000

Others Institutions Holding EBS

# of Institutions

177

Shares Held

38.3M

Call Options Held

94.1K

Put Options Held

153K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $324M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Emergent Bio Solutions Inc. Transaction History